ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - hpv-16 l1; hpv-18 l1 - תרחיף להזרקה - hpv-18 l1 20 mcg / 0.5 ml; hpv-16 l1 20 mcg / 0.5 ml - bacterial and viral vaccines, combined - cervarix is a vaccine for use from the age of 9 years for the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic human papillomavirus (hpv) types.

ישראל - עברית - Ministry of Health

medici medical ltd, israel - diphtheria toxoid; filamentous haemagglutinin (fha); fimbrae tupes 2 + 3 (fim); pertactin (prn); pertussis toxoid vaccine; poliovirus type 1; poliovirus type 2; poliovirus type 3; prp of haemophilus infl. type b; tetanus toxoid - תרחיף להזרקה - pertactin (prn) 3 mcg ml; diphtheria toxoid 15 lf ml; tetanus toxoid 5 lf ml; pertussis toxoid vaccine 20 mcg ml; filamentous haemagglutinin (fha) 20 mcg ml; fimbrae tupes 2 + 3 (fim) 5 mcg ml; poliovirus type 1 40 du ml; poliovirus type 2 8 du ml; poliovirus type 3 32 du ml; prp of haemophilus infl. type b 10 mcg ml - bacterial and viral vaccines, combined - pediacel is indicated for immunization of children at or above the age of 2 months and as a booster in children up to their 7th birthday against diphtheria, tetanus, whooping cough, poliomyelitis and invasive haemophilus influenzae type b disease. in infants, three infectons are to be given intramuscularly at 2, 4 and 6 months of age followed by a booster at 18 months of age. children who have had pertusis, tetanus, diphtheria or haemophilus influenzae type b invasive disease should still be immunized since these clinical infections do not always confer immunity. children who have had natural pertussis can continue to receive pertussis - containing vaccines. human immunodeficiency virus (hiv) infected persons hiv- infected individuals, both asymptomatic and symptomatic, should be immunized with pediacel vaccine according to standard schedules.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - ceftiofur hydrochloride 50 mg / 1 ml - suspension for injection - infections associated with bacteria sensitive to ceftiofur: in pigs : for the treatment of bacterial respiratory disease associated with pasteurella multocida actinobacillus pleuropneumoniae adn streptococcus suis. in cattle : for the treatment of bacterial respiratory disease associated with mannheimia spp. (pasteurella haemolytica) pasteurella multocida and haemophilus somnus. for the treatment of acute interdigital necrobacillosis ( panaritium foot rot) associated with fusobacterium necrophorum adn bacteroides melaninogenicus (porphyromonas asaccharolytica). for treatment of the bacterial coponent of acute post-partum (puerperal) metritis within 10 days after calving associated with escherichia coli arcanobacterium pyogenes and fusobacteriu necrophorum sensitive to ceftiofur.

ישראל - עברית - Ministry of Health

abic veterinary products ltd - enrofloxacin - תמיסה - enrofloxacin 100 mg/ml

ישראל - עברית - Ministry of Health

romat ltd - lincomycin hydrochloride 56.7 mg/ml; spectinomycin hydrochloride 150 mg/ml - solution for injection - for infections caused by the following bacteria: staphylocococcus spp, streptococcus spp, diplococcus spp., corynebacterium spp., bacillus spp.,clostridium spp., coliform bacteria, klebsiella spp., salmonella spp., haemophilus spp., brucella spp., pasteurella spp., leptospira spp., bordetella spp., coccidia, campylobacter spp., fusobacterium spp., treponema spp., mycoplasma spp. cattle: respiratory diseased, enteritis, foot infections, mastitis, clostridiosis, mycoplasmosis. swine: pneumonia (bacteria/mycoplasma), bloody scours, septic arthritis, bacterial enteritis, pneumonia (haemophilus).

ישראל - עברית - Ministry of Health

allergan israel ltd - gatifloxacin 3 mg/ml - ophthalmic solution - gatifloxacin - zymar is indicated for the treatment of bacterial conjunctivitis caused by suspectible strains of the following organisms : aerobic gram - positive bacteria : cornyebacterium propinquum - staphylococcus aureus - staphylococcus epidermidis - streptococcus mitis - streptococcus pneumoniae. aerobic gram - negative bacteria : - haemophilus influenza. - efficacy for this organisms was studied in fewer than 10 infections.

ישראל - עברית - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ישראל - עברית - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ישראל - עברית - Ministry of Health

kamada ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 5 g / 100 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in adults, and children and adolescents in:- primary immunodeficiency syndromes with impaired antibody production - hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed- hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation- congenital aids with recurrent bacterial infectionsimmunomodulation in adults, and children and adolescents in:- primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count- guillain barr? syndrome- kawasaki disease

ישראל - עברית - Ministry of Health

takeda israel ltd - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 100 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - ivig can be used in all age ranges, unless otherwise specified below.replacement therapy in:primary immunodeficiency syndromes with impaired antibody production.hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.children and adolescents (age 0-18) with congenital aids and recurrent bacterial infections.hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (hsct).immunomodulationprimary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count.guillain barr? syndrome.kawasaki disease.